Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TILDRAKIZUMAB vs TILDRAKIZUMAB-ASMN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TILDRAKIZUMAB vs TILDRAKIZUMAB-ASMN: Safety Overview

Metric TILDRAKIZUMAB TILDRAKIZUMAB-ASMN
Total FAERS Reports 869 1,621
Deaths Reported 89 92
Death Rate 10.2% 5.7%
Hospitalizations 389 69
Average Patient Age 57.9 yrs 63.8 yrs
% Female Patients 42.5% 53.8%
Manufacturer Sun Pharmaceutical Industries, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status N/A Prescription